Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Coronary Heart Disease | Research article

Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study)

Authors: Francisco M. Gutierrez-Mariscal, Antonio García-Ríos, Purificación Gómez-Luna, Carolina Fernández-Gandara, Magdalena P. Cardelo, Silvia de la Cruz-Ares, Fernando Rodriguez-Cantalejo, Raul M. Luque, Ana León-Acuña, Javier Delgado-Lista, Pablo Perez-Martinez, Elena M. Yubero-Serrano, Jose Lopez-Miranda

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Aging is associated with a high risk for cardiovascular disease. The relation of obesity and risk of cardiovascular events appears to be more closely linked to certain clinical or metabolic phenotypes than to obesity itself. Our aim was to establish whether aging influenced the metabolic phenotypes regarding to cardiovascular risk, evaluated by changes in the intima media thickness-common carotid (IMT-CC), in coronary heart disease (CHD) patients.

Methods

In this cross-sectional study, 1002 CHD patients were studied at entry from the CORDIOPREV study. We performed carotid ultrasound assessment to obtain their IMT-CC values. Carotid atherosclerosis was considered to exist if IMT-CC > 0.7 mm.

Results

Age determined a higher IMT-CC, regardless metabolic phenotype (all p < 0.05). Metabolically healthy non-obese (MHNO) aged< 60 showed a lesser prevalence for carotid atherosclerotic disease than metabolically sick non-obese (MSNO) and obese (MSO), while MHNO aged≥60 only showed less prevalence for the disease than the MSO. Carotid atherosclerosis associated with age, sex, impaired fasting glucose (IFG), hypertension and high sensitivity C-reactive protein (hsCRP). However, in patients aged< 60, it associated with sex and IFG and in the age ≥ 60 group, with hypertension and hsCRP.

Conclusions

Our results suggest that CHD patients aged≥60 are less metabolic flexible compared to patients aged< 60. Thus, MHO patients aged≥60 show the same risk of suffering carotid atherosclerosis as those with metabolic disease, while MHO patients aged< 60 show lower risk than MSO. This fact indicates the need to focus on therapeutic strategies in order to modify those parameters related to obesity and metabolic inflexibility in patients with CHD before entering old age.
Appendix
Available only for authorised users
Literature
1.
go back to reference Aparicio HJ, et al. Overweight, obesity, and survival after stroke in the framingham heart study. J Am Heart Assoc. 2017;6:e004721.CrossRef Aparicio HJ, et al. Overweight, obesity, and survival after stroke in the framingham heart study. J Am Heart Assoc. 2017;6:e004721.CrossRef
2.
go back to reference Arnlov J, Sundstrom J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men Diabetes care. Diabetes Care. 2011;34:61–5.CrossRef Arnlov J, Sundstrom J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men Diabetes care. Diabetes Care. 2011;34:61–5.CrossRef
3.
go back to reference Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring). 2013;21:203–9.CrossRef Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring). 2013;21:203–9.CrossRef
4.
go back to reference Choi KM, et al. Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol. 2013;79:364–70.CrossRef Choi KM, et al. Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol. 2013;79:364–70.CrossRef
8.
go back to reference Guo F, Garvey WT. Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: stability of metabolic health status in adults. Obesity (Silver Spring). 2016;24:516–25.CrossRef Guo F, Garvey WT. Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: stability of metabolic health status in adults. Obesity (Silver Spring). 2016;24:516–25.CrossRef
9.
go back to reference Hamer M, Bell JA, Sabia S, Batty GD, Kivimaki M. Stability of metabolically healthy obesity over 8 years: the English longitudinal study of ageing. Eur J Endocrinol. 2015;173:703–8.CrossRef Hamer M, Bell JA, Sabia S, Batty GD, Kivimaki M. Stability of metabolically healthy obesity over 8 years: the English longitudinal study of ageing. Eur J Endocrinol. 2015;173:703–8.CrossRef
13.
go back to reference Kim HN, Kim SH, Eun YM, Song SW. Obesity with metabolic abnormality is associated with the presence of carotid atherosclerosis in Korean men: a cross-sectional study. Diabetol Metabol Syndrome. 2015;7:68.CrossRef Kim HN, Kim SH, Eun YM, Song SW. Obesity with metabolic abnormality is associated with the presence of carotid atherosclerosis in Korean men: a cross-sectional study. Diabetol Metabol Syndrome. 2015;7:68.CrossRef
17.
go back to reference Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag health study), Norway. J Am Coll Cardiol. 2014;63:1071–8.CrossRef Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag health study), Norway. J Am Coll Cardiol. 2014;63:1071–8.CrossRef
23.
go back to reference Rohde LE, et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18:1765–70.CrossRef Rohde LE, et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18:1765–70.CrossRef
25.
go back to reference Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371:1547–9.CrossRef Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371:1547–9.CrossRef
27.
go back to reference Stein JH, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima-media thickness task force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111; quiz 189-190. https://doi.org/10.1016/j.echo.2007.11.011.CrossRefPubMed Stein JH, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima-media thickness task force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111; quiz 189-190. https://​doi.​org/​10.​1016/​j.​echo.​2007.​11.​011.CrossRefPubMed
Metadata
Title
Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study)
Authors
Francisco M. Gutierrez-Mariscal
Antonio García-Ríos
Purificación Gómez-Luna
Carolina Fernández-Gandara
Magdalena P. Cardelo
Silvia de la Cruz-Ares
Fernando Rodriguez-Cantalejo
Raul M. Luque
Ana León-Acuña
Javier Delgado-Lista
Pablo Perez-Martinez
Elena M. Yubero-Serrano
Jose Lopez-Miranda
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01544-5

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue